ALHC241018C12500
- 0.24
- -0.06-20.00%
Alignment Healthcare Newsroom
William Blair Initiates Alignment Healthcare(ALHC.US) With Buy Rating
Alignment Healthcare Analyst Ratings
Stifel Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Maintains Target Price $14
Stifel Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Raises Target Price to $14
Buy Rating Affirmed for Alignment Healthcare on Strong Growth and Operational Efficiency Prospects Into 2025
Alignment Healthcare Analyst Ratings
TD Cowen Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Raises Target Price to $10
Piper Sandler Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Raises Target Price to $10
Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), Alignment Healthcare (ALHC) and Akoya Biosciences (AKYA)
Alignment Healthcare Analyst Ratings
Barclays Maintains Underweight on Alignment Healthcare, Raises Price Target to $7
TD Cowen Initiates Alignment Healthcare(ALHC.US) With Buy Rating, Announces Target Price $10
Barclays Maintains Alignment Healthcare(ALHC.US) With Sell Rating, Maintains Target Price $7
Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (ALHC), Exact Sciences (EXAS) and Fulcrum Therapeutics (FULC)
Buy Rating Justified: Alignment Healthcare's Strong Q2 Performance and Positive 2025 Outlook
Analysts Conflicted on These Healthcare Names: Owens & Minor (OMI), Tandem Diabetes Care (TNDM) and Alignment Healthcare (ALHC)
UBS Adjusts Price Target on Alignment Healthcare to $9 From $6.50, Maintains Neutral Rating
BofA Securities Maintains Alignment Healthcare(ALHC.US) With Buy Rating
Stifel Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Maintains Target Price $12
TD Cowen Sticks to Their Buy Rating for Alignment Healthcare (ALHC)